AI is stepping in to help speed up the diagnosis of COVID-19 and expedite how much time healthcare professionals spend determining COVID-19 pneumonia and non-COVID-19 cases.

It may be time to take a long last look at the vision exam that relies on a cardboard sheet of huge letters at the top and tiny ones at the bottom.

The World Health Organization announced it will resume a clinical trial evaluating the efficacy of hydroxychloroquine for COVID-19 patients after the organization halted it following studies showing higher risks to patients taking the drug.

U.S. Army researchers are calling for the creation of a national emergency network that would coordinate select digital health technologies, including AI, in fighting COVID-19 now and other public health crises later.

Cerner is partnering with 252-bed American Hospital Dubai to open a medical AI research center in the United Arab Emirates.

The Lancet has issued four corrections to a research paper that found COVID-19 patients who used the drug hydroxychloroquine have a higher risk of death.

Johns Hopkins radiologists have repurposed a deep learning algorithm designed to detect tuberculosis on chest x-rays to, instead, help identify COVID-19.

The European Union has certified AI software for reading mammograms, clearing the way for a South Korea-based AI vendor to sell another of its AI products across the European Economic Area.